Jama Pitman, SVP, Chief Development Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,267 shares at $15.62 ($35K) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Open-market sale of $35k DCPH by SVP, Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DCPH | SELL | 2023-10-31 | $17K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $18K | — | Filing → |
| DCPH | SELL | 2023-02-17 | $18K | — | Filing → |